Evidence of altered homocysteine metabolism in chronic renal failure

Nephron

Volumn 83, Issue 4, 1999, Pages 314-322

  Henning, Bernhard F ^a   Riezler, Reiner ^b   Tepel, Martin ^a   Langer, Klaus ^c   Raidt, Holger ^c   Graefe, Ulrich ^c   Zidek, Walter ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Severi Med GmBH   (Germany)

^c KfH Dialysis Center   (Germany)

Author keywords

Alterations, homocysteine levels; Chronic renal failure; Homocysteine metabolism

Indexed keywords

CREATININE; CYANOCOBALAMIN; CYSTATHIONINE; FOLIC ACID; HOMOCYSTEINE; METHIONINE; METHYLMALONIC ACID; PYRIDOXINE;

ADULT; AMINO ACID METABOLISM; ARTICLE; CHRONIC KIDNEY FAILURE; CREATININE BLOOD LEVEL; FEMALE; GAS CHROMATOGRAPHY; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

EID: 0032731968     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045423     Document Type: Article

References (47)

1. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995;274:1049-1057.
2. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH: A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992;268:877-881.
3. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PWF, Belanger AJ, O'Leary DH, Wolf PA, Schaefer FJ, Rosenberg IH: Association between plasma homocysteine concentrations and extracranial carotid artery stenosis. N Engl J Med 1995;332:286-291.
4. Arnesen E, Refsum H, Býnaa KH, Ueland PM, Fýrde OH, Nordrehaug JE: Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995;24:704-709.
5. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG: Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346:1395-1398.
6. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH: Total homocysteine in plasma or serum: Methods and clinical applications. Clin Chem 1993;39:1764-1779.
7. Selhub J, Miller JW: The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 1992;55:131-138.
8. Mudd SH, Levy HL, Skovby F: Disorders of transsulfuration; in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic Basis of Inherited Diseases. New York, McGraw-Hill, 1989, vol 1, pp 693-734.
9. Rosenberg IH, Fenton WA: Disorders of propionate and methylmalonate metabolism; in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic Basis of Inherited Diseases. New York, McGraw-Hill, 1989, vol 1, pp 821-844.
10. Stabler SP, Marcell PD, Podell ER, Allen RH, Lindenbaum J: Assay of methylmalonic acid in the serum of patients with cobalamin deficiency using capillary gas chromatography-mass spectrometry. J Clin Invest 1986;77:1606-1612.
11. Allen RH, Stabler SP, Savage DG, Lindenbaum J: Elevation of 2-methytcitric acid I and II levels in serum, urine, and cerebrospinal fluid of patients with cobalamin deficiency. Metabolism 1993;42:978-988.
12. Kang SS, Passen EL, Ruggie N, Wong PW, Sora H: Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation 1993;88:1463-1469.
13. Kang SS, Wong PW, Susmano A, Sora J, Norusis M, Ruggie N: Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease. Am J Hum Genet 1991;48:536-545.
14. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R: A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-113.
15. Goyette P, Frosst P, Rosenblatt DS, Rozen R: Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet 1995;56:1052-1059.
16. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I: Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991;324: 1149-1155.
17. Bostom AG, Lathrop L: Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 1997;52:10-20.
18. Cohen BD, Patel H, Kornhauser RS: Alternate reasons for atherogenesis in uremia. Proc Clin Dial Transplant Forum 1977;7:178-180.
19. Wilcken DEL, Gupta VJ: Sulphur-containing amino acids in chronic renal failure with particular reference to homocysteine and cysteinehomocysteine mixed disulphide. Eur J Clin Invest 1979;9:301-307.
20. Wilcken DEL, Gupta VJ, Betts AK: Homocysteine in the plasma of renal transplant recipients: Effect of cofactors for methionine metabolism. Clin Sci 1981;61:743-749.
21. Smolin LA, Laidlaw SA, Kopple JD: Altered plasma-free and protein-bound sulfur amino acid levels in patients undergoing maintenance hemodialysis. Am J Clin Nutr 1987;45:737-743.
22. Chauveau P, Chadefaux B, Coude M, et al: Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 1993;43(suppl 41):72-77.
23. Stabler SP, Lindenbaum J, Savage DG, Allen RH: Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency. Blood 1993;81:3404-3413.
24. Kim SS, Hirose S, Tamura H, Nagasawa R, Tokushima H, Mitarai T, Isoda K: Hyperhomocysteinemia as a possible role for atherosclerosis in CAPD patients. Adv Perit Dial 1994; 10:282-285.
25. Massy ZA, Chadefaux-Vekemans B, Chevalier A, Bader CA, Drücke TB, Legendre C, Lacour B, Kamoun P, Kreis H: Hyperhomocysteineamia: A significant risk factor for cardiovascular disease in renal transplant recipients. Nephrol Dial Transplant 1994;9:1103-1108.
26. Arnadottir M, Hultberg B, Vladov V, Nilsson-Ehle P, Thysell H: Hyperhomocysteinemia in cyclosporin-treated renal transplant recipients. Transplantation 1996;61:509-512.
27. Bostom AG, Shemin D, Lapane KL, Miller JW, Sutherland P, Nadeau M, Seyoum E, Hartman W, Prior R, Wilson PW, et al: Hyperhomocysteinemia and traditional cardiovascular disease riks factors in end-stage renal disease patients on dialysis: A case-control study. Atherosclerosis 1995;114:93-103.
28. Bachmann J, Tepel M, Raidt H, Riezler R, Graefe U, Langer K, Zidek W: Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients. J Am Soc Nephrol 1995; 6:121-125.
29. Shemin D, Lapane KL, Bausserman L, Kanaan E, Dworkin L, Bostom AG: Plasma total homocysteine and hemodialysis access thrombosis: A prospective study. J Am Soc Nephrol 1999; 10:1095-1099.
30. Perna AF, Ingrosso D, Castaldo P, De Santo NG, Galletti P, Zappia V: Homocysteine, a new crucial element in the pathogenesis of uremic cardiovascular complications. Miner Electrolyte Metab 1999;25:95-99.
31. Brattström L, Lindgrcn A, Israelsson B, Malinow MR, Norrving B, Upson B, Hamfelt A: Hyperhomocysteinaemia in stroke: Prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur J Clin Invest 1992; 22:214-221.
32. Cockroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
33. Stabler SP, Marcell PD, Podell ER, Allen RH: Quantitation of total homocysteine, total cysteine, and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry. Anal Biochem 1987;162:185-196.
34. Allen RH, Stabler SP, Lindenbaum J: Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism. Metabolism 1993;42:1448-1460.
35. 6 occur commonly in elderly people. Am J Clin Nutr 1993; 58:468-476.
36. Norusis MJ (ed): Advanced Statistics. Chicago, SPSS, 1988.
37. Ueland PM, Refsum H: Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989;114:473-501.
38. House JD, Brosnan ME, Brosnan JT: Renal uptake and excretion of homocysteine in rats with acute hyperhomocysteinemia. Kidney Int 1998;54:1601-1607.
39. Hultberg B, Andersson A, Sterner G: Plasma homocysteine in renal failure. Clin Nephrol 1993;40:230-234.
40. Foreman JW, Wlad H, Blumberg G, Pepe LM, Segal S: Homocystine uptake in isolated rat renal cortical tubules. Metabolism 1982;31: 613-619.
41. van Guldener C, Donker AJM, Jakobs C, Teerlink T, de Meer K, Stehouwer CDA: No net renal extraction of homocysteine in fasting humans. Kidney Int 1998;54:166-169.
42. Perna AF, Ingrosso D, De Santo NG, Galletti P, Zappia F: Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia. Kidney Int 1995;47: 247-253.
43. Guttormsen AB, Ueland PM, Svarstad E, Refsum H: Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney Int 1997;52:495-502.
44. Dudman NPB, Tyrrell PA, Wilcken DEL: Homocysteinemia: Depressed plasma serine levels. Metabolism 1987;36:198-202.
45. Arnadottir M, Brattström L, Simonsen O, Thyssell H, Hultberg B, Andersson A, Nilsson-Ehle P: The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin Nephrol 1993;40:236-240.
46. Savage DG, Lindenbaum J, Stabler SP, Allen RH: Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 1994;96:239-246.
47. Bocock MA, Zlotkin SH: Hepatic sulfur amino acid metabolism in rats with chronic renal failure. J Nutr 1990;120:691-699.